• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Eledon Pharmaceuticals Inc (NQ: ELDN )

    2.465 -0.005 (-0.20%)
    Streaming Delayed Price Updated: 3:37 PM EDT, Jul 9, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Headline News about Eledon Pharmaceuticals Inc

    < Previous 1 2 3 Next >
    Penny Stock Picks: 3 Companies Poised to Graduate to the Big Leagues
    You don’t want to overlook these three penny stocks filled to the brim with the potential to make huge leaps in their respective markets. 
    Via InvestorPlace
    3 High-Potential Penny Stocks to Turn $1000 into $1 Million: June 2024
    Although the very idea of millionaire-maker penny stocks implies incredibly high risks, if all cylinders fire, these companies could fly. 
    Via InvestorPlace
    12 Health Care Stocks Moving In Friday's After-Market Session
    Via Benzinga
    ELDN Stock Earnings: Eledon Pharma Beats EPS for Q1 2024
    ELDN stock results show that Eledon Pharma beat analyst estimates for earnings per share the first quarter of 2024. 
    Via InvestorPlace
    Nano-Cap Eledon Pharmaceuticals' Investigational Drug Shows Safety In Early Organ Transplant Study, Analyst Boosts Forecast On Increased Confidence
    Eledon Pharmaceuticals' results from islet cell transplant trial for type 1 diabetes, with tegoprubart showing safety and efficacy in kidney transplant patients. Analysts anticipate significant... 
    Via Benzinga
    Expert Ratings for Eledon Pharma
    Via Benzinga
    Recap: Eledon Pharma Q1 Earnings
    Via Benzinga
    Eledon Pharma's Earnings: A Preview
    Via Benzinga
    Eledon Pharmaceuticals's Earnings: A Preview
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    ELDN Stock Earnings: Eledon Pharma Beats EPS for Q4 2023
    ELDN stock results show that Eledon Pharma beat analyst estimates for earnings per share the fourth quarter of 2023. 
    Via InvestorPlace
    Kidney Transplant From Genetically Edited Pig: Boston Patient With End-Stage Renal Disease Becomes First To Receive
    Eledon Pharmaceuticals announces successful use of tegoprubart in kidney xenotransplant. Promising results show its potential to prevent rejection, marking a significant milestone in organ... 
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    Eledon Pharma: Q2 Earnings Insights
      Eledon Pharma (NASDAQ:ELDN) reported its Q2 earnings results on Thursday, August 11, 2022 at 04:01 PM. Here's what investors need to know about the announcement. 
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For September 27, 2023
    Via Benzinga
    Stocks That Hit 52-Week Lows On Tuesday
      On Tuesday, 56 companies set new 52-week lows. 
    Via Benzinga
    Stocks That Hit 52-Week Lows On Thursday
      On Thursday, 64 companies achieved new lows for the year. 
    Via Benzinga
    Why Chewy Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket
    Gainers Airspan Networks Holdings Inc. (NYSE: MIMO) shares rose 58.9% to $0.3754 in pre-market trading. Airspan Networks recently reported new financing and leadership changes. 
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
    It's time to start the day with a breakdown of the biggest pre-market stock movers that traders need to know about for Thursday morning! 
    Via InvestorPlace
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Gainers Metacrine (NASDAQ:MTCR) shares rose 13.8% to $0.54 during Tuesday's after-market session. This security traded at a volume of 3.0 million shares come close, making up 948.6% of its average... 
    Via Benzinga
    Eledon Shares Climb After Securing FDA Nod For Mid-Stage Kidney Disease Study
    Eledon Pharmaceuticals (NASDAQ: ELDN) received clearance from the U.S. Food and Drug Administration (FDA) for its Investigational New Drug (IND) application to evaluate tegoprubart for the treatment of... 
    Via Benzinga
    Eledon Pharmaceuticals Earnings: A Preview
      Eledon Pharmaceuticals (NASDAQ:ELDN) is set to give its latest quarterly earnings report on Thursday, 2022-08-11. Here's what investors need to know before the announcement. 
    Via Benzinga
    Recap Of Monday's Biotech Catalysts - End Of the Day Summary
    Via Benzinga
    Daily Biotech Pulse: Celyad Resumes Colorectal Cancer Trial, Setback For Otonomy, AstraZeneca Halts Phase 3 Head, Neck Cancer Trial
    Here's a roundup of top developments in the biotech space over the last 24 hours: 
    Via Benzinga
    Eledon Secures FDA Clearance For Kidney Transplant Rejection Study
    The U.S. Food and Drug Administration (FDA) has cleared the Eledon Pharmaceuticals’ (NASDAQ: ELDN) Investigational New Drug (IND) application to evaluate Tegoprubart for the prevention of organ... 
    Via Benzinga
    Recap of Monday's Biotech Catalysts - End of the Day Summary
    Abbvie (NYSE: ABBV) has submitted a marketing authorization application (MAA) to the European Medicines Agency (EMA) for atogepant for the prophylaxis of migraine in adult patients who have at least... 
    Via Benzinga
    < Previous 1 2 3 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.